QuantuMDx Group Limited Revenue and Competitors

Newcastle, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • QuantuMDx Group Limited's estimated annual revenue is currently $19.8M per year.(i)
  • QuantuMDx Group Limited's estimated revenue per employee is $155,000

Employee Data

  • QuantuMDx Group Limited has 128 Employees.(i)
  • QuantuMDx Group Limited grew their employee count by -9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

QuantuMDx Group is a multinational life science, tools and diagnostics company with a global vision: to revolutionise molecular diagnostics and help eradicate disease by making accurate diagnostics universally accessible. We have invented the Q-POC, which compresses a molecular diagnostics laboratory into a simple-to-use, portable, affordable device. For just a few pounds per test, it can be used anywhere from basic under-the-tree settings to clinics and hospitals, providing results within 20 minutes. With its high-quality testing for diseases such as TB, HPV and STIs, the battery-operated device aims to bring the power of precision medicine to health professionals globally, enabling patients to be tested, diagnosed and given treatment options in one efficient consultation. Our aim is for geotagged pathogen data from each connected Q-POC to facilitate global disease surveillance and mapping, promoting a joined-up approach to disease control and eradication. Our technologies also have potential utility across many markets including sample preparation, concentration of pathogens from large and complex samples (CAPTURE-XT) and the detection of DNA from humans and pathogens (Q-POC). Headquartered in the UK, QuantuMDx has operations and global partnerships with healthcare providers in the United States, Asia, Europe and Africa keeping it at the forefront of molecular diagnostics.

keywords:N/A

N/A

Total Funding

128

Number of Employees

$19.8M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

QuantuMDx Group Limited's People

NameTitleEmail/Phone
1
Assay TechnicianReveal Email/Phone
2
Senior Quality Control OfficerReveal Email/Phone
3
QC ManagerReveal Email/Phone
4
Senior Electronic EngineerReveal Email/Phone
5
Supply Chain CoordinatorReveal Email/Phone
6
Manufacturing Science & Technology Team LeadReveal Email/Phone
7
Early Stage Assay Development Team LeadReveal Email/Phone
8
Team Lead Mechanical Design EngineerReveal Email/Phone
9
QMS ManagerReveal Email/Phone
10
VP FinanceReveal Email/Phone

QuantuMDx Group Limited News

2022-04-17 - Handheld DNA Readers Market Size, Outlook And Forecast ...

Handheld DNA Readers Market Size, Outlook And Forecast | QuantuMDx Group, Oxford Nanopore Technologies, Ubiquitome Limited, Cepheid.

2021-11-08 - QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech Funds will be used to develop further multiplexing capabilities and menu expansion in collaboration with Sansure, on the Q-POC™ device Cooperation Agreement to ...

2014-01-10 - British biotech startup turns to crowdfunding to help eliminate malaria

A British biotechnology startup is developing a hand-held diagnostic device that it claims can help eradicate malaria. The Newcastle-based company, QuantuMDx, is the brainchild of molecular biologist Jonathan O’Halloran. He got the idea over a decade ago when he invented a new DNA sequencing de ...

2012-11-05 - Biomedical Catalyst funds QuantuMDx’s nanowire technology

Biomedical Catalyst funds QuantuMDx’s nanowire technology 05-11-2012 The government-backed Biomedical Catalyst programme announced major funding for the ground-breaking Q-CANCER project, which will integrate QuantuMDx Group’s rapid on-chip lab processes and develop the first sub-20 minute “tum ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.2M129-12%N/A
#2
$27.5M13115%N/A
#3
$29.2M1399%N/A
#4
$42.2M14225%N/A
#5
$45.9M1446%N/A